{"id":"W1971439170","doi":"10.1182/blood-2007-12-128918","title":"Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; Takeda Oncology; Astellas Pharma; CellGenix; American Society for Blood and Marrow Transplantation; Kiadis Pharma; Therakos; WellPoint; Teva Pharmaceutical Industries; HistoGenetics; Medical College of Wisconsin; StemCyte; Enzon Pharmaceuticals; U.S. Navy; Osiris Therapeutics; Celgene; American International Group; Pfizer; Baxter International; GlaxoSmithKline; U.S. Department of Health and Human Services; Astellas Pharma US; Health Resources and Services Administration; Viropharma; Amgen; Blue Cross and Blue Shield Association; Cerus Corporation; Bristol-Myers Squibb; Bayer HealthCare; U.S. Department of Defense","keywords":"Medicine; Internal medicine; Gastroenterology; Transplantation; White blood cell; Leukemia; Acute lymphocytic leukemia; Surgery; Acute leukemia; Lymphoblastic Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001754238,0.0003943864,0.0006905348,0.0005124997,0.0001306957,0.00001112555,0.0002596492,0.0003014471,0.0001131413],"category_scores_gemma":[0.0001841601,0.000306537,0.00007803821,0.001201746,0.0002968465,0.0001625233,0.00006218081,0.0006313139,0.0001013347],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001747608,"about_ca_system_score_gemma":0.001791525,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001217651,"about_ca_topic_score_gemma":0.0007681244,"domain_scores_codex":[0.9970466,0.00009559606,0.0006065306,0.0006929524,0.0007488918,0.0008093696],"domain_scores_gemma":[0.9984452,0.00049648,0.0001168635,0.0004449002,0.0001268733,0.0003696514],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08789582,0.008461902,0.6428415,0.003533747,0.002728448,0.1603795,0.0478555,0.004485682,0.03682576,0.0001278751,0.00398325,0.0008810264],"study_design_scores_gemma":[0.2550902,0.004262177,0.6439648,0.0152334,0.0007480829,0.01635576,0.0006390272,0.0443986,0.01726681,0.00009715548,0.0004624727,0.001481513],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961864,0.0001171442,0.0001463228,0.0007054975,0.00004052894,0.0009971985,0.00007198547,0.000101085,0.001633775],"genre_scores_gemma":[0.9976599,0.0005806077,0.001009202,0.0001700113,0.00007538601,0.00008388045,0.0001091103,0.00007213603,0.0002398284],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1671944,"threshold_uncertainty_score":0.9999387,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01679573464968815,"score_gpt":0.243223031356176,"score_spread":0.2264272967064879,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}